Clinical trial
Clinical Efficacy of Inhibition of Organ Dysfunction Through Bermekimab in Systemic Sclerosis: A Proof- Of-Concept Double-Blind Randomized Clinical Trial (the Light Trial)
NCT04045743 is registered in ClinicalTrials.gov with Hellenic Institute for the Study of Sepsis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Efficacy of Inhibition of Organ Dysfunction Through Bermekimab in Systemic Sclerosis: A Proof- Of-Concept Double-Blind Randomized Clinical Trial (the Light Trial)
- Lead sponsor
- Hellenic Institute for the Study of Sepsis
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 19, 2019
- Completion date
- July 19, 2021
- Enrollment
- 20 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.